FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca Mercks shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.…
Is D-Wave Quantum a Better Quantum Computing Stock to Buy Than IonQ? If everyone only invested in what they fully understood, I suspect quite a few stocks wouldnt exist today. We can…
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.…
Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors Astrazeneca (AZN) closed the most recent trading day at $71.93, moving -1.24% from the previous trading session.…
Total Voting Rights 2 June 2025 Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds By Reuters Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds…
Danaher Partners With AstraZeneca to Support Precision Medicine DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient selection and making…
Why Tempus AI Stock Plummeted This Week Extending the more-than-4% slide that they experienced last week, shares of Tempus AI (NASDAQ: TEM) have suffered an even more…
A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today Shares of Tempus AI (NASDAQ: TEM) are falling on Wednesday. One of Cathie Woods largest holdings, the companys stock plummeted…
Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy? Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.…
AZN Gets CHMP Nod for Imfinzi in Muscle-Invasive Bladder Cancer AstraZeneca wins CHMP nod for Imfinzi combo in muscle-invasive bladder cancer, based on data from the phase III NIAGARA study.…
Swedish Business Consortium to build AI Factory with NVIDIA · AstraZeneca, Ericsson, Saab, SEB and Wallenberg Investments to tap new sovereign AI infrastructure · NVIDIA to open AI…